Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jay H Hoofnagle

Showing results (1-10 of 164) with videos related to

Pageof 17
Sort By:
Hepatology (Baltimore, Md.)|June 27, 2006
The National Commission on Digestive DiseasesJay H Hoofnagle
Hepatology (Baltimore, Md.)|April 11, 2020
FXR Agonists as Therapy for Liver DiseaseJay H Hoofnagle
Hepatology (Baltimore, Md.)|April 2, 2004
Biliary Atresia Research Consortium (BARC)Jay H Hoofnagle
Journal of Hepatology|January 8, 2004
Challenges in therapy of chronic hepatitis BJay H Hoofnagle
Journal of Hepatology|January 23, 2016
Hepatic decompensation during direct-acting antiviral therapy of chronic hepatitis CJay H Hoofnagle
Hepatology (Baltimore, Md.)|April 29, 2009
Reactivation of hepatitis BJay H Hoofnagle
Hepatology (Baltimore, Md.)|September 22, 2005
Hepatitis BJay H Hoofnagle
Hepatology (Baltimore, Md.)|December 20, 2013
Introducing the AASLD President: Adrian Di BisceglieJay H Hoofnagle
Hepatology (Baltimore, Md.)|October 31, 2002
Course and outcome of hepatitis CJay H Hoofnagle
The New England Journal of Medicine|May 1, 2009
A step forward in therapy for hepatitis CJay H Hoofnagle
Pageof 17

Showing results (1-10 of 164) with videos related to

Sort By:
Pageof 17
Hepatology (Baltimore, Md.)|June 27, 2006
The National Commission on Digestive DiseasesJay H Hoofnagle
Hepatology (Baltimore, Md.)|April 11, 2020
FXR Agonists as Therapy for Liver DiseaseJay H Hoofnagle
Hepatology (Baltimore, Md.)|April 2, 2004
Biliary Atresia Research Consortium (BARC)Jay H Hoofnagle
Journal of Hepatology|January 8, 2004
Challenges in therapy of chronic hepatitis BJay H Hoofnagle
Journal of Hepatology|January 23, 2016
Hepatic decompensation during direct-acting antiviral therapy of chronic hepatitis CJay H Hoofnagle
Hepatology (Baltimore, Md.)|April 29, 2009
Reactivation of hepatitis BJay H Hoofnagle
Hepatology (Baltimore, Md.)|September 22, 2005
Hepatitis BJay H Hoofnagle
Hepatology (Baltimore, Md.)|December 20, 2013
Introducing the AASLD President: Adrian Di BisceglieJay H Hoofnagle
Hepatology (Baltimore, Md.)|October 31, 2002
Course and outcome of hepatitis CJay H Hoofnagle
The New England Journal of Medicine|May 1, 2009
A step forward in therapy for hepatitis CJay H Hoofnagle
Pageof 17